Blog: Engaging Innovation

Authored on

And

April 14, 2021

Watch Now: Discussion on Eligibility Criteria and the Impact on Access to Clinical Trials

On Friday, April 9, ASCO and Friends of Cancer Research (Friends) co-hosted a live virtual event, which brought together experts from across the healthcare sector to discuss the recent release of the…

Learn more

Grace Collins | February 17, 2021

Shaping the Future of Emerging Immunotherapies and Cell Therapies

On February 11, 2021, Friends of Cancer Research (Friends) hosted a virtual meeting highlighting and discussing the progress, challenges, and future of immunotherapies and cell therapies. Ellen Sigal…

Learn more

Eric Hua | November 23, 2020

Friends Annual Meeting Day 2: Optimizing the Use of Accelerated Approval Meeting Summary

The second of two sessions for the Friends of Cancer Research (Friends) Annual Meeting was held on November 19th. Day 2 featured a shift from Modernizing Expedited Development Pathways to a focus on…

Learn more

Eric Hua | November 23, 2020

Friends Annual Meeting Day 1: Modernizing Expedited Development Programs Meeting Summary

On November 13, 2020, Friends of Cancer Research (Friends) held the first of two virtual sessions of the Friends Annual Meeting. Day 1 covered Modernizing Expedited Development Programs, which…

Learn more

Natalie Kim | November 15, 2020

Optimizing the Use of Accelerated Approval

The first white paper, “Modernizing Expedited Development Programs” focused on expediting the development of drugs at the pre-clinical and clinical stages. On Day 2 of the 2020 Friends of Cancer…

Learn more

Natalie Kim | November 10, 2020

Modernizing Expedited Development Programs

Each year, the Friends of Cancer Research (Friends) Annual Meeting addresses critical issues in the development of new oncology drugs and features experts proposing unique approaches toward current…

Learn more

Eric Hua | October 1, 2020

An International Framework for Real-World Evidence - Day 2: Regulatory and Policy Needs for RWE

Day 2 of the Friends of Cancer Research (Friends) meeting on real-world evidence (RWE) turned the focus from Day 1 to the regulatory and policy implications of real-world evidence. The hour-long…

Learn more

Watch Now: Discussion on Eligibility Criteria and the Impact on Access to Clinical Trials

Shaping the Future of Emerging Immunotherapies and Cell Therapies

Friends Annual Meeting Day 2: Optimizing the Use of Accelerated Approval Meeting Summary

Friends Annual Meeting Day 1: Modernizing Expedited Development Programs Meeting Summary

Optimizing the Use of Accelerated Approval

Modernizing Expedited Development Programs

An International Framework for Real-World Evidence - Day 2: Regulatory and Policy Needs for RWE

Shaping the Future of Emerging Immunotherapies and Cell Therapies

An International Framework for Real-World Evidence - Day 1: RWE Pilot Project Results

ctMoniTR Step 1 Results: Do Changes in ctDNA reflect response to treatment?